Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
First-in-human dose-escalating trial of E. coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors. Chung, T., Rosenthal, E., Parker, W. B., Allan, P., Clemons, L., Lowman, D., Hong, J., Hunt, F. R., Richman, J., Conry, R., Mannion, K., Carroll, W., Nabell, L., Sorscher, E. J. AMER SOC CLINICAL ONCOLOGY. 2015
View details for Web of Science ID 000358036900717